Table: Santen Pharm -2020/21 group forecast(IFRS)
Apr 13 (Reuters) -
Santen Pharmaceutical Co Ltd
CONSOLIDATED EARNINGS ESTIMATES
(in billions of yen unless specified)
Full Year to Full Year to
Mar 31, 2021 Mar 31, 2021
LATEST PREVIOUS
FORECAST FORECAST
Sales 249.00 235.00
Operating 14.50 35.00
PreTax 14.00 34.00
EPS Basic 18.27 yen 58.35 yen
NOTE - Santen Pharmaceutical Co Ltd.(Figures are reported based on international accounting rules (IFRS).)
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4536.T